RETRO Study (RETrograde Renal Access Outcomes)
RetroPerc®-A Prospective, Multi-institutional Trial of Efficacy of the RetroPerc Device
1 other identifier
observational
150
1 country
2
Brief Summary
The goal of this observational study is to learn about the benefit of using RetroPerc® in obtaining renal access for percutaneous nephrolithotomy. The device is already used in routine clinical practice by urologists around the country. Participants who are already scheduled to undergo percutaneous nephrolithotomy as part of their regular care will be asked to participate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2024
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 6, 2024
CompletedFirst Submitted
Initial submission to the registry
July 8, 2025
CompletedFirst Posted
Study publicly available on registry
July 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
May 4, 2026
May 1, 2026
2.3 years
July 8, 2025
May 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of successful renal access per access attempts
The proportion of successful renal access was compared to the renal access attempts (e.g. 100 success attempts/110 attempts).
Procedure
Secondary Outcomes (4)
Location of Renal Access
Procedure
Time to gain renal access
Procedure
Total Procedure Time
Procedure
Length of Post-Operative Hospital Stay
Day 0 to 3 Months Post-Operative
Study Arms (1)
Percutaneous Nephrolithotomy
Participants with a single renal stone or total sum of 1.5 to 3 cm in maximum dimension of multiple stones undergoing percutaneous nephrolithotomy as part of their routine medical care using the RetroPerc® system to obtain renal access.
Interventions
Eligibility Criteria
Participants undergoing percutaneous nephrolithotomy for treatment of their renal stone (s) total linear sum of 1.5 to 3cm cm in maximum dimension.
You may qualify if:
- Renal stone or total linear sum of 1.5-3cm cm in maximum dimension (largest diameter in axial or coronal)--- multiple stones should be summed to determine stone size.
- Age \>=18 years of age
- Gender: both men and women included.
- Ethnic background: all ethnicities will be included in the study population and the specific ethnic diversity present in the study population will reflect the geographic distributions of the participating institutions.
- Plan for PCNL in the supine position
You may not qualify if:
- Active pregnancy
- BMI \>45
- Severe Hydronephrosis - renal pelvis diameter \> 20mm
- Flank window \< 4 cm are ineligible for puncture
- Previous ipsilateral PCNL
- Currently with "useful" nephrostomy tube on ipsilateral side
- Uncorrectable coagulopathies
- Untreated urinary tract infection
- Subjects with significant morbidities such as American Society of Anesthesiologists (ASA) score ≥ 4, severe spinal cord injuries, severe cardiopulmonary insufficiency, uncontrolled diabetes, neurological disorders, bedbound, anticipated life expectancy less than 5 years, or any other comorbidity, that in the opinion of the principal investigator could represent an increased peri-operative risk for the subject;
- Ipsilateral partial nephrectomy
- History of ipsilateral ureteral reimplantation or ureteral reconstruction;
- History of Simple or radical prostatectomy
- History of cystectomy
- History of calyceal diverticula stone;
- History of renal donation or transplant;
- +9 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Kansas Medical Centerlead
- RetroPerc Inccollaborator
Study Sites (2)
University of South Florida
Tampa, Florida, 33606, United States
University of Kansas Medical Center
Kansas City, Kansas, 66105, United States
Related Publications (14)
Lee CL, Anderson JK, Monga M. Residency training in percutaneous renal access: does it affect urological practice? J Urol. 2004 Feb;171(2 Pt 1):592-5. doi: 10.1097/01.ju.0000104849.25168.6d.
PMID: 14713766BACKGROUNDAlotaibi KM. Retrograde nephrostomy access for percutaneous nephrolithotomy: a simple and safe technique. Urolithiasis. 2020 Apr;48(2):175-181. doi: 10.1007/s00240-019-01135-z. Epub 2019 Apr 29.
PMID: 31037404BACKGROUNDKaler KS, Parkhomenko E, Lin CY, Valley ZA, Kim WK, Okhunov Z, Patel RM, Landman J. A New Twist on an Old Technique: Lawson Retrograde Endoscopic-Guided Nephrostomy Access for Percutaneous Nephrolithotomy in Prone Split-Leg Position. J Endourol Case Rep. 2018 Nov 29;4(1):190-194. doi: 10.1089/cren.2018.0073. eCollection 2018.
PMID: 30515460BACKGROUNDWynberg JB, Paik LJ, Odom BD, Kruger M, Atalla CS. Body mass index predicts outcome of ureteroscopy-assisted retrograde nephrostomy for percutaneous nephrolithotomy. J Endourol. 2014 Sep;28(9):1071-7. doi: 10.1089/end.2014.0204. Epub 2014 Jun 12.
PMID: 24779944BACKGROUNDSivalingam S, Al-Essawi T, Hosking D. Percutaneous nephrolithotomy with retrograde nephrostomy access: a forgotten technique revisited. J Urol. 2013 May;189(5):1753-6. doi: 10.1016/j.juro.2012.11.169. Epub 2012 Dec 3.
PMID: 23219545BACKGROUNDAl-Otaibi KM. Retrograde upper-pole calyceal access for percutaneous nephrolithotripsy of stones in the lower-pole calyx. Arab J Urol. 2012 Dec;10(4):353-7. doi: 10.1016/j.aju.2012.08.002. Epub 2012 Sep 23.
PMID: 26558049BACKGROUNDKawahara T, Ito H, Terao H, Kato Y, Uemura H, Kubota Y, Matsuzaki J. Effectiveness of ureteroscopy-assisted retrograde nephrostomy (UARN) for percutaneous nephrolithotomy (PCNL). PLoS One. 2012;7(12):e52149. doi: 10.1371/journal.pone.0052149. Epub 2012 Dec 14.
PMID: 23251698BACKGROUNDSmiths Textbook of Endourology. 2007, BC Decker Publ. Ch. 15, Dr. D. Hosking - "Retrograde Nephrostomy", Pg. 117.
BACKGROUNDMokulis JA, Peretsman SJ. Retrograde percutaneous nephrolithotomy using the Lawson technique for management of complex nephrolithiasis. J Endourol. 1997 Apr;11(2):125-30. doi: 10.1089/end.1997.11.125.
PMID: 9107586BACKGROUNDWong HY, Hinson JL, Griffith DP. Retrograde nephrostomy: advantages, disadvantages, and the learning curve. J Endourol. 1995 Dec;9(6):461-3. doi: 10.1089/end.1995.9.461.
PMID: 8775075BACKGROUNDMorrisseau PM, Trotter SJ. Retrograde percutaneous nephrolithotomy: urological treatment of a urological problem. J Urol. 1988 Jun;139(6):1163-5. doi: 10.1016/s0022-5347(17)42847-3.
PMID: 3373578BACKGROUNDSpirnak JP, Resnick MI. Retrograde percutaneous stone removal using modified Lawson technique. Urology. 1987 Dec;30(6):551-3. doi: 10.1016/0090-4295(87)90434-1.
PMID: 3686771BACKGROUNDHunter PT, Hawkins IF, Finlayson B, Nanni G, Senior D. Hawkins-Hunter retrograde transcutaneous nephrostomy: a new technique. Urology. 1983 Dec;22(6):583-7. doi: 10.1016/0090-4295(83)90300-x.
PMID: 6649222BACKGROUNDLawson RK, Murphy JB, Taylor AJ, Jacobs SC. Retrograde method for percutaneous access to kidney. Urology. 1983 Dec;22(6):580-2. doi: 10.1016/0090-4295(83)90299-6.
PMID: 6649221BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bristol Whiles, MD
University of Kansas Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 8, 2025
First Posted
July 17, 2025
Study Start
December 6, 2024
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
May 4, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP, CSR
- Time Frame
- Following end of study
- Access Criteria
- Data may be requested by participating study investigators. The participating sites must have a data use agreement in place before requesting access to the data.
De-identified participant data collected during the study